Personalized therapy guided by single-cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10 AML with extensive extramedullary infiltration: A case report
Br J Haematol
.
2024 Oct;205(4):1444-1449.
doi: 10.1111/bjh.19522.
Epub 2024 May 13.
Authors
Rong Wang
1
,
Yue Wu
2
,
Ruicong Xue
1
,
Ting Shi
3
,
Haifeng Gu
2
,
Yichen Yang
2
,
Weizhen Wu
2
,
Yunmei Yang
2
,
Shu Sun
3
,
Hong-Hu Zhu
3
4
Affiliations
1
Department of Hematology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
2
Department of Geriatrics, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
3
Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
4
Chinese Institutes for Medical Research, Beijing, China.
PMID:
38740515
DOI:
10.1111/bjh.19522
No abstract available
Keywords:
AML; extramedullary infiltration; personalized therapy.
Grants and funding
2022C03005/Key Research and Development Programme of Zhejiang
DFL20240301/"Dengfeng" Talent Training Program of Beijing Hospitals Authority